DNDI-0690

N/A

Report date: 2025/07/03 20:00:09
NME

Base Information

Drug NameDNDI-0690
Drug Alias NameDNDI-0690
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA inhibitors
TargetsDNA
Therapy Area/IndicationsLeishmaniasis, VisceralLeishmaniasis, Cutaneous
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsLeishmaniasis, VisceralLeishmaniasis, Cutaneous

Other Information

ATC CodeN/A
Related LinksN/A